MedPath

Challenge ResCare: Behaviours that challenge in dementia care

Not Applicable
Completed
Conditions
Dementia
Mental and Behavioural Disorders
Unspecified dementia
Registration Number
ISRCTN02553381
Lead Sponsor
Humber Teaching NHS Foundation Trust
Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28783270 results

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1200
Inclusion Criteria

1. Identification of homes (clusters):
Within the trial area, an invitation to participate in the trial will be sent to all care homes with 25+ beds listed on the website of the Care Quality Commission (CQC) as old age care homes, with a rating of 'good' or 'excellent', (a) with nursing care and (b) without nursing care. Homes specialising in care of residents with dementia will not be excluded.
2. Consent of care home residents

Exclusion Criteria

1. Residents whose stay in the home is not, in the judgement of the home manager, likely to be for long term care - for example those receiving respite care
2. Residents who are in the palliative stages of a disease at the time of recruitment
3. Residents who are unable to speak/understand English
4. Residents who enter the home part way through the study or who are out of the home (for example in hospital) at the time of data collection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Neuropsychiatric Inventory with Caregiver Distress Scale (NPI-D) This is a validated measure based on informant interview and designed to rate frequency, severity and caregiver distress for 12 Challenging Behaviour categories - delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, apathy/indifference, disinhibition, irritability/lability, aberrant motor behaviour, sleep, appetite/eating disorders. The primary research question will be addressed by analysis of the frequency and severity scores.<br> Outcome will be measured at baseline, 4 months and 12 months<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath